Shares of 3SBio Receive a Boost, Up 5.8% - Financial News Network Online |
![]() |
Financial News Network Online The Company researches treatments in the areas of nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. Over the past year, 3SBio has traded in a range of $9.50 to $20.00 and is now at $10.61, 12% above that low. |